Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fasting glucose level reduction induced by imatinib in chronic myeloproliferative disease with TEL-PDGFRβ rearrangement and type 1 diabetes.

× No keyword cloud information.

5 in total

1. Fusion of platelet-derived growth factor receptor β to CEV14 gene in chronic myelomonocytic leukemia: A case report and review of the literature.

Authors: Sheng-Lan Gong; Meng-Qiao Guo; Gu-Sheng Tang; Chun-Ling Zhang; Hui-Ying Qiu; Xiao-Xia Hu; Jian-Min Yang
Journal: Oncol Lett Date: 2015-11-18 Impact factor: 2.967

2. A PPARγ transcriptional cascade directs adipose progenitor cell-niche interaction and niche expansion.

Authors: Yuwei Jiang; Daniel C Berry; Ayoung Jo; Wei Tang; Robert W Arpke; Michael Kyba; Jonathan M Graff
Journal: Nat Commun Date: 2017-06-26 Impact factor: 14.919

3. Tyrosine kinase inhibitors of Ripk2 attenuate bacterial cell wall-mediated lipolysis, inflammation and dysglycemia.

Authors: Brittany M Duggan; Kevin P Foley; Brandyn D Henriksbo; Joseph F Cavallari; Akhilesh K Tamrakar; Jonathan D Schertzer
Journal: Sci Rep Date: 2017-05-08 Impact factor: 4.379

4. Effect of imatinib on plasma glucose concentration in subjects with chronic myeloid leukemia and gastrointestinal stromal tumor.

Authors: Miguel Ángel Gómez-Sámano; Jorge Enrique Baquerizo-Burgos; Melissa Fabiola Coronel Coronel; Buileng Daniela Wong-Campoverde; Fernando Villanueva-Martinez; Diego Molina-Botello; Jose Alonso Avila-Rojo; Lucía Palacios-Báez; Daniel Cuevas-Ramos; Francisco Javier Gomez-Perez; Alejandro Zentella-Dehesa; Álvaro Aguayo-González; Alfonso Gulias-Herrero
Journal: BMC Endocr Disord Date: 2018-11-03 Impact factor: 2.763

Review 5. Tyrosine Kinase Targeting: A Potential Therapeutic Strategy for Diabetes.

Authors: Mohammad Althubiti
Journal: Saudi J Med Med Sci Date: 2022-09-07

5 in total